Alerus Financial NA Sells 1,512 Shares of The Clorox Company (NYSE:CLX)

Alerus Financial NA decreased its position in shares of The Clorox Company (NYSE:CLX) by 2.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 57,492 shares of the company’s stock after selling 1,512 shares during the quarter. Alerus Financial NA’s holdings in Clorox were worth $9,366,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Prospera Private Wealth LLC bought a new stake in shares of Clorox during the third quarter worth $27,000. Innealta Capital LLC acquired a new stake in Clorox in the second quarter worth about $30,000. Trifecta Capital Advisors LLC raised its holdings in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares during the last quarter. Family Firm Inc. acquired a new position in Clorox during the 2nd quarter valued at about $31,000. Finally, Quarry LP boosted its stake in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 11.40 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.57% of the stock is owned by insiders.

Analysts Set New Price Targets

Several brokerages recently weighed in on CLX. Citigroup increased their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. DA Davidson increased their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Evercore ISI decreased their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. BNP Paribas raised Clorox to a “strong sell” rating in a research note on Friday, September 6th. Finally, TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and boosted their target price for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Five investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of “Hold” and a consensus price target of $155.00.

Clorox Stock Performance

Shares of CLX opened at $167.17 on Friday. The firm has a market cap of $20.69 billion, a P/E ratio of 58.25, a PEG ratio of 3.09 and a beta of 0.41. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.35. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The firm’s 50 day moving average price is $163.09 and its two-hundred day moving average price is $149.39.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm’s revenue was up 27.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.49 EPS. On average, analysts forecast that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.92%. Clorox’s payout ratio is presently 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.